Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
22 participants
OBSERVATIONAL
2021-05-04
2023-05-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
No studies evaluated the influence of keratoconus on stress at work, nor the influence of treatments of keratoconus on stress at work, including Quality of Life at work and on perception of work. Moreover, it has been shown that some pathologies had greater influence in some occupations, also depending on other characteristics of individuals such as age, sex or socio professional groups.
Therefore, we hypothesized that keratoconus 1) will influence stress at work including QoL at work and perception of work, 2) will have a greater influence in some occupations and depending on age, sex, or stage of keratoconus, 3) will induce stoppage of work and occupational reclassifications.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Keratoconus, Cross-linking and Cross-linking Combined With Topo-guided Photorefractive Keratectomy on Self-reported Quality of Life. A Three-year Update.
NCT01845714
CHOICE OF SUBJECTIVE OCULAR REFRACTION TECHNIQUE AND CORNEAL TOPOGRAPHY OF KERATOCONUS
NCT04174209
Correlation Between Eye Rubbing and Keratoconus Severity in a Treatment-naive Keratoconic Population
NCT02883881
Validation Study on Eye Rubbing Questionnaire in Patients With or Suspected of Having a Keratoconus (KC)
NCT04517903
The Collagen Factors of Rapid Progression of Keratoconus in Children.
NCT06722937
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Stress at work is measured by Job Content Questionnaire of Karasek issued during consultations.
Study all workers the influence of keratoconus and its stage on:
* consequences of keratoconus in function of visual acuity, mode of correction and staging of the keratoconus.
* Psychological consequences: Quality of life at work, Perception of work (Karasek questionnaire), anxiety and depression (HAD scale)
* Professional consequences: stoppage of work and duration and occupational reclassifications
* Characteristics of the patient: age, sex, occupation.
Measures to reduce or avoid bias:
* Standardized, anonymous auto questionnaire
* A large workforce: high rate of participation is expected
* Inclusion of control group.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
KERATOCONUS group
All workers with keratoconus all stages followed at the service of ophthalmology in CHU Gabriel Montpied, Clermont-Ferrand, Auvergne.
The investigators only assessed data from usual routine practice. Patients answer the auto questionnaire in last minutes of consultation.
auto-questionnaire
Patients answer the auto questionnaire in last minutes of consultation.
CONTROL group
workers with good visual acuity consulting in ophthalmology service of Clermont-Ferrand.
The investigators only assessed data from usual routine practice. Patients answer the auto questionnaire in last minutes of consultation.
auto-questionnaire
Patients answer the auto questionnaire in last minutes of consultation.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
auto-questionnaire
Patients answer the auto questionnaire in last minutes of consultation.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patients constituting a representative control group of workers consulting in ophthalmology service of Clermont-Ferrand.
Exclusion Criteria
* minors subjects
* inability to provide informed consent
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Clermont-Ferrand
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Frédéric DUTHEIL
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Clermont-Ferrand
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU - Gabriel Montpied
Clermont-Ferrand, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018-A02527-48
Identifier Type: OTHER
Identifier Source: secondary_id
RNI 2018 DUTHEIL 2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.